EFTR - eFFECTOR Therapeutics announces 1-for-25 reverse stock split
2024-01-09 08:22:33 ET
More on eFFECTOR Therapeutics
- eFFECTOR updates Phase 1/2 data for breast cancer therapy
- eFFECTOR stock rises after FDA fast track status for breast cancer therapy
- Seeking Alpha’s Quant Rating on eFFECTOR Therapeutics
- Historical earnings data for eFFECTOR Therapeutics
- Financial information for eFFECTOR Therapeutics
For further details see:
eFFECTOR Therapeutics announces 1-for-25 reverse stock split